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SUMMARY 
Cutaneous leishmaniasis has recently been discov-
ered in some parts of Ghana. The case of an HIV 
infected patient presenting with cutaneous 
leishmaniasis at the Korle-Bu Teaching Hospital is 
discussed. The diagnosis of leishmaniasis was con-
firmed by histology.  Also highlighted is the fact 
that this is the first reported case of dual infection 
of HIV and Leishmaniasis in Ghana.    
   
The possibility of rapid spread to other members 
of the community, both immunecompetent and 
immunesuppressed in view of the large numbers of 
organisms present in the lesion is discussed.   
 
INTRODUCTION 
Leishmaniasis is a disease caused by parasitic pro-
tozoa of the leishmania species and is now en-
demic in eighty-eight countries in the five conti-
nents1.   It presents in two main forms: visceral and 
cutaneous.  Visceral leismaniasis (VL) is caused 
by L donovani  and runs a fatal course without 
treatment while cutaneous leishmaniasis (CL) is 
caused by L major (a range of species) and can be 
very disfiguring.  Leishmaniasis is transmitted by 
sand flies but can be transmitted directly from per-
son to person through the sharing of needles, as is 
often the case in intravenous drug users2.   This 
group is the main group at risk of co-infection. 
 
AIDS and Visceral Leishmaniasis are locked in a 
vicious cycle of mutual reinforcement since they 
both attack the cell-mediated immune system.  
AIDS increases the risk of VL by 100-1000 times 
in endemic areas2.   In the revised WHO Clinical 
Staging for HIV for the African region, visceral 
leismaniasis is assigned to WHO stage 4 which 
implies severe immune suppression3. 
 
Cutaneous leishmaniasis can become disseminated 
(diffuse cutaneous leishmaniais) (DCL) especially 
in immunesuppressed persons.  The illness can go 
on for years and does not heal spontaneously. Pa-
tients with HIV/AIDS are particularly susceptible. 
 
In Ghana, an outbreak of cutanoeus leishmanisis 
hitherto unknown occurred in 2003 starting from 
the Ho district.  This soon spread to 2 adjacent 
districts in the Volta region4. Efforts to identify the 
secondary host by researchers of the Noguchi 
Memorial Institute for Medical Research and the 
Ghana Health Service have so far not yielded fruit-
ful results5 whilst the species of the proposed vec-
tors in the outbreak area were so so low that their 
vectorial role remains uncertain5. 
 
CASE 
A case of dual infection is presented after in-
formed consent was obtained from the patient. 
A 38 year old HIV positive female patient pre-
sented to the Fevers Unit of the Korle Bu Teaching 
Hospital for further management. She lived in 
New Longoro-Bamboi in the Brong-Ahafo region, 
was married and a mother of 6 children. 
 
The main physical finding was pruritic papular 
dermatitis. Clinically she was staged as World 
Health Organisation (WHO) stage 2 but further 
workup showed a CD4 count of 14 and thus pa-
tient was prepared for antiretroviral therapy, which 
she started in October 2004. 
 
In February 2005, three months after initiating 
antiretroviral therapy, she presented with a large 
painful infected ulcer at the base of the neck.  She 
presented two more times for drug refills until July 
of the same year when she presented with a gener-
alised rash and complained of being unwell.  
 
Examination showed generalised concentric hy-
perpigmented granulomatous tender lesions with 
raised edges. (Figures 1 and 2).  Some of the le-
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 Differential diagnoses of granulomatous candidi-
asis, tinea nigra or cutaneous tuberculosis were 
considered. 
 
Figure 1 Arm lesions 
 
Figure 2  Facial lesions 
 
Punch biopsies of the lesions were sent for histol-
ogy at the pathology laboratory of the Korle-Bu 
Teaching Hospital.  Histology which showed in-
tradermal and subcutaneous aggregrates of lym-
phocytes and plasma cells as well as many free 
small cells, ovoid to round in shape identified as 
leishmania and confirmed with geimsa staining.  
Few of the organisms were within histiocytes. 
(Figure 3) The features are in keeping with cu-




Figure 3 Clusters of free Leishmania in interstitial tissue 
and subcutaneous fat as shown in Haematoxylin and 
Eosin stain 
Patient however defaulted treatment after10 




Cutaneous leishmaniasis is limited to certain geo-
graphical areas, mainly the old world i.e. Sudan, 
Ethiopia, Kenya, India, Middle East etc and the 
new world namely Brazil, Mexico and the United 
States of America but spreading fast because of 
improved travel and migration2.   It is spread by 
sand flies although human to human transmission 
is possible. 
 
The disease starts as an erythematous papule at the 
site of the bite, usually an exposed site, however in 
the black skin it starts as a hyperpigmented papule. 
The papule then becomes a nodule, which then 
ulcerates with raised distinct borders. Ulcers are 
typically large and painless unless there is secon-
dary infection.  There may be multiple lesions and 
lesions up to 200 have been described in a single 
patient.  The skin lesions can be very disfiguring 
and may heal but recidivans is common. Treatment 
is with destructive methods and antimony com-
pounds. 
 
Cases of Leishmania/HIV co-infections are being 
reported more frequently in various parts of the 
world and it is anticipated that the number of co-
infections will rise and be no longer restricted to 
endemic areas2.   West Africa has no official sur-
veillance system yet, but several cases have been 
reported: Cameroon(1), Guinea Bissau(1), Mali (4) 
and Senegal (2)2.  This is the first reported case 
from Ghana. 
 
Hirtheto unknown in Ghana, new cases emerged in 
the Ho district and soon spread to the Hohoe and 
Kpandu districts in the Volta region4.  Presently 
due to the break-up of two of the districts: Ho dis-
trict into Ho and Adaklu-Anyigbe and Kpandu into 
Kpandu and South Dayi, the disease is known to 
be present in five districts4. The case presented 
hailed from the Brong Ahafo region and may re-
flect the spread of the disease northwards or from 
the Northern endemic5 belt downwards.  
 
Leishmania/HIV co-infections can lead to epide-
miological changes, which modify the traditional 
patterns of zoonotic VL. Coinfected patients har-
bour a high number of organisms in their blood 
thus there is the risk of being reservoirs of the dis-
ease thus resulting in increased risks of future epi-
demics.  Sand flies can be infected through a very 
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hypodermic needle2. As to whether the same risks 
of contributions to future epidemics can be said for 
cutaneous disseminated disease where immune-
suppression results in multiple organisms being 
extracellular  is yet to be confirmed.  However 
spread of infections to other immune suppressed 
patients is real and efforts at case detection, dis-
ease control and treatment should be accelerated. 
2. The Leishmaniases and Leishmania/HIV co-
infections. WHO fact sheet. Accessed 




3. Interim WHO Clinical Staging of HIV/AIDS 
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